Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AARTI DRUGS vs BLISS GVS PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AARTI DRUGS BLISS GVS PHARMA AARTI DRUGS/
BLISS GVS PHARMA
 
P/E (TTM) x 21.9 13.1 167.8% View Chart
P/BV x 3.3 1.3 247.0% View Chart
Dividend Yield % 0.2 0.4 52.2%  

Financials

 AARTI DRUGS   BLISS GVS PHARMA
EQUITY SHARE DATA
    AARTI DRUGS
Mar-23
BLISS GVS PHARMA
Mar-23
AARTI DRUGS/
BLISS GVS PHARMA
5-Yr Chart
Click to enlarge
High Rs53291 581.9%   
Low Rs31167 461.8%   
Sales per share (Unadj.) Rs293.372.2 406.4%  
Earnings per share (Unadj.) Rs18.07.4 243.8%  
Cash flow per share (Unadj.) Rs23.49.2 255.4%  
Dividends per share (Unadj.) Rs1.000.50 200.0%  
Avg Dividend yield %0.20.6 37.7%  
Book value per share (Unadj.) Rs128.884.0 153.3%  
Shares outstanding (eoy) m92.60104.15 88.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.41.1 130.6%   
Avg P/E ratio x23.410.8 217.8%  
P/CF ratio (eoy) x18.08.7 207.9%  
Price / Book Value ratio x3.30.9 346.4%  
Dividend payout %5.66.8 82.0%   
Avg Mkt Cap Rs m39,0038,262 472.1%   
No. of employees `000NANA-   
Total wages/salary Rs m804862 93.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m27,1617,516 361.4%  
Other income Rs m22178 12.3%   
Total revenues Rs m27,1827,694 353.3%   
Gross profit Rs m3,0951,173 263.8%  
Depreciation Rs m503187 269.5%   
Interest Rs m371104 358.3%   
Profit before tax Rs m2,2421,061 211.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m578293 197.1%   
Profit after tax Rs m1,664767 216.8%  
Gross profit margin %11.415.6 73.0%  
Effective tax rate %25.827.7 93.3%   
Net profit margin %6.110.2 60.0%  
BALANCE SHEET DATA
Current assets Rs m14,9236,974 214.0%   
Current liabilities Rs m9,3301,933 482.8%   
Net working cap to sales %20.667.1 30.7%  
Current ratio x1.63.6 44.3%  
Inventory Days Days639 14.8%  
Debtors Days Days1,1621,871 62.1%  
Net fixed assets Rs m9,2904,562 203.7%   
Share capital Rs m926104 889.1%   
"Free" reserves Rs m10,9988,646 127.2%   
Net worth Rs m11,9248,750 136.3%   
Long term debt Rs m2,047407 503.0%   
Total assets Rs m24,21411,535 209.9%  
Interest coverage x7.011.2 62.6%   
Debt to equity ratio x0.20 369.1%  
Sales to assets ratio x1.10.7 172.2%   
Return on assets %8.47.6 111.3%  
Return on equity %14.08.8 159.1%  
Return on capital %18.712.7 147.1%  
Exports to sales %31.40-   
Imports to sales %33.40-   
Exports (fob) Rs m8,536NA-   
Imports (cif) Rs m9,082NA-   
Fx inflow Rs m8,5365,618 151.9%   
Fx outflow Rs m9,3521,225 763.7%   
Net fx Rs m-8164,394 -18.6%   
CASH FLOW
From Operations Rs m1,342343 391.1%  
From Investments Rs m-1,640-78 2,115.5%  
From Financial Activity Rs m165-249 -66.3%  
Net Cashflow Rs m-13230 -438.0%  

Share Holding

Indian Promoters % 57.5 35.0 164.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.4 22.0 33.5%  
FIIs % 2.1 15.4 13.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 42.5 65.0 65.4%  
Shareholders   170,414 40,758 418.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AARTI DRUGS With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on AARTI DRUGS vs BLISS GVS PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AARTI DRUGS vs BLISS GVS PHARMA Share Price Performance

Period AARTI DRUGS BLISS GVS PHARMA S&P BSE HEALTHCARE
1-Day -2.52% -1.71% 1.18%
1-Month -14.00% -9.48% -0.75%
1-Year 24.37% 57.63% 61.82%
3-Year CAGR -15.33% 3.76% 18.16%
5-Year CAGR 21.63% -8.82% 19.79%

* Compound Annual Growth Rate

Here are more details on the AARTI DRUGS share price and the BLISS GVS PHARMA share price.

Moving on to shareholding structures...

The promoters of AARTI DRUGS hold a 57.5% stake in the company. In case of BLISS GVS PHARMA the stake stands at 35.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AARTI DRUGS and the shareholding pattern of BLISS GVS PHARMA.

Finally, a word on dividends...

In the most recent financial year, AARTI DRUGS paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 5.6%.

BLISS GVS PHARMA paid Rs 0.5, and its dividend payout ratio stood at 6.8%.

You may visit here to review the dividend history of AARTI DRUGS, and the dividend history of BLISS GVS PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.